Sir -Wald and his colleagues (1990) disagree with Darby and Pike (1988) as to whether the increase in lung cancer risk observed in epidemiological studies in non-smokers in association with exposure to environmental tobacco smoke (ETS) is too large to be satisfactorily explained in terms of their relatively small exposure to tobacco smoke constituents. This is surprising as the discrepancy between the epidemiology and the dosimetry is really very striking. Table I summarises evidence from those 18 epidemiological studies in which risk, relative to a non-ETS exposed never smoker ('Control'), could be estimated both for an ETS exposed never smoker ('Passive') and an ever smoker ('Active'). It (Wald & Ritchie, 1984) for a somewhat higher figure of 1.5%, but their mean value for exposed non-smokers inappropriately includes some individuals with high cotinine levels that were presumably actually smokers. Not only is there approximately an order of magnitude difference between the cotinine results and the epidemiology, but it seems probable that cotinine overestimates the degree of lung exposure from passive relative to active smoking. Whereas in mainstream smoke, nicotine is mainly in the particulate phase and is absorbed through the lungs, nicotine in ETS is mainly in the vapour phase and, being water soluble can be absorbed through the mucous membranes. Arundel et al. (1987) have estimated that relative to an average smoker, an average non-smoker retains in the lung 0.02% (males) or 0.01% (females) of the amount of smoking-related particulate matter retained by a smoker. Even multiplying these percentages by two or three to make them applicable to ETS-exposed non-smokers rather than non-smokers in general gives a percentage which is over two orders of magnitude less than the percentage indicated by the epidemiology.
What could be the source of this large discrepancy? Darby and Pike make it clear that it is not duration of exposure, which in any case could well be on average shorter for living with a smoker than for being a smoker. Nor is it because the dosimetry relates to current smoking whereas the epidemiology relates to lifetime smoking as the difference in risk between a current and an ever smoker is much smaller than the size of the discrepancy. Remmer (1987) , who also notes the large discrepancy, considers it to be explained by nonsmokers being more susceptible to the effects of passive smoking than smokers, because active smoking induces enzymes that protect smokers against these effects, but this explanation seem unattractive and poorly supported by the available evidence. In my view, a much more plausible explanation is that the epidemiological evidence is severely (Lee, 1989) . I have discussed the last of these in detail elsewhere (Lee, 1987; Lee, 1988) and have shown clearly that previous attempts to correct for it (Wald et al., 1986 ; US National Academy of Science's Committee on Passive smoking, 1986) have been inadequate.
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